Ironwood Pharmaceuticals (IRWD) Stock Price & Analysis

IRWD$4.83-0.02 -0.41%
Drug Manufacturers - Specialty & GenericValue StockGrowth StockHigh Quality
Compare
Market cap$799.61MEnterprise value$724.44MRevenue (TTM)$400.30MMarket position—

Score

90
Bullish
Value
95
Quality
100
Growth
74

AI Analysis

Snapshot

Ironwood Pharmaceuticals doesn’t screen as a clean setup today — Stocklytics 90/100 leaves more to prove. Under the hood: P/E 5.3, about 69% below its own multi-year median, plus revenue compounding ~-10% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

95
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

74
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

100
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Ironwood Pharmaceuticals, Inc. (IRWD) last printed $4.83. Equity value is $799.61M. Trailing earnings multiple 5.34. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$273.96M$298.28M$346.64M$428.41M$389.52M$413.75M$410.6M$442.74M$351.41M$296.15M

About

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the CONSTELLA brand throughout Canada and the European Union. Beyond its marketed offerings, Ironwood's development pipeline includes IW-3300, another GC-C agonist targeting various visceral pain conditions, such as interstitial cystitis/bladder pain syndrome and endometriosis. Additionally, the company is advancing CNP-104, an immune nanoparticle being investigated for biliary cholangitis. Ironwood maintains key strategic alliances with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. to support the ongoing development and market introduction of linaclotide. Established in 1998, the Boston, Massachusetts-based firm initially operated as Microbia, Inc. before officially rebranding to Ironwood Pharmaceuticals, Inc. in April 2008.

Ironwood Pharmaceuticals (IRWD) Stock Price & Analysis

IRWD price $4.83 -0.02 -0.41%

Ticker
IRWD
Price
$4.83
Change
-0.02 -0.41%
Market cap
$799.61M
P/E
5.34
Forward P/E
2.81
Dividend yield
0.00%
Beta
0.24
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stocklytics score
90
Value
95
Quality
100
Growth
74

Stocklytics score rationale: value 95, quality 100, growth 74.

Fair value

IRWD fair value $44.12. Price $4.83. Price is 89% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 88% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value blends a 10-year DCF and an earnings multiple: the average of the DCF value and an earnings value from next-twelve-months EPS times 23.8, a blend of the Healthcare median (30.7) and the stock's own 10-year median (17.0). How we calculate it →

Model uncertainty high for this stock

Compare IRWD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-02-24—0.38—140.93M
2026-11-050.360.32133.04M121.57M
2026-08-060.310.32113.04M114.84M
2026-05-070.240.07106.51M92.11M
2026-02-25-0.010.0247.71M50.92M
2025-11-100.240.09122.06M74.71M
2025-08-070.14-0.0285.24M60.77M
2025-05-07-0.23-0.0541.14M45.90M
2025-02-270.020.1290.55M93.77M
2024-11-070.020.0891.59M91.22M
2024-08-08-0.010.1594.40M107.10M
2024-05-09-0.020.1974.88M105.75M
2024-02-15-0.010.21117.55M117.47M
2023-11-090.090.16113.74M114.00M
2023-08-080.310.25107.38M103.70M
2023-05-040.250.24104.06M100.35M
2023-02-160.270.27107.20M108.04M
2022-11-030.280.27108.64M109.15M
2022-08-040.210.3097.23M103.55M
2022-05-050.210.2697.53M96.62M
2022-02-170.270.31117.13M110.17M
2021-11-040.330.31103.75M106.42M
2021-08-050.340.23104.03M104.03M
2021-05-060.240.2188.84M90.17M
2021-02-170.360.29116.68M111.95M
2020-11-050.230.15103.47M67.48M
2020-08-060.160.0989.43M73.78M
2020-05-060.040.0579.94M99.93M
2020-02-130.300.24126.30M101.04M
2019-10-310.400.11131.17M36.07M
2019-07-300.10-0.03102.22M30.66M
2019-05-02-0.26-0.1468.73M54.68M
2019-02-13-0.02-0.15130.69M980.19M
2018-11-06-0.38-0.1765.69M57.38M
2018-08-06-0.28-0.2181.11M60.83M
2018-05-01-0.27-0.2369.16M58.95M
2018-02-15-0.14-0.1894.21M121.11M
2017-11-02-0.18-0.2286.83M106.09M
2017-08-03-0.30-0.2265.08M51.15M
2017-05-08-0.36-0.2052.17M45.19M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-15DENNER ALEXANDER JBuy3.69K——
2026-07-20Silber JeffreyBuy137.04K——
2026-07-20Silber JeffreyOther0——
2026-07-07Silver RonaldSell127.89K$4.52578.06K
2026-06-16Shepard JayBuy63.48K——
2026-06-16Kessler Marla LBuy63.48K——
2026-06-16Currie Mark GBuy63.48K——
2026-06-16Duane Jon RBuy63.48K——
2026-06-16DENNER ALEXANDER JBuy63.48K——
2026-06-16McHugh JulieBuy63.48K——
2026-06-16McHugh JulieSell21.57K$3.7380.46K
2026-06-16Moukheibir CatherineBuy63.48K——
2026-06-15DENNER ALEXANDER JBuy4.07K——
2026-05-19Silver RonaldBuy25.00K——
2026-03-17DENNER ALEXANDER JSell6.72M$3.0520.51M
2026-03-17DENNER ALEXANDER JSell5.80K$3.3119.20K
2026-03-13DENNER ALEXANDER JBuy4.45K——
2026-03-10John MinardoBuy136.61K——
2026-03-10Martini Gregory S.Buy136.61K——
2026-03-10Gaskins Tammi LBuy136.61K——
2026-03-10Shetzline MichaelBuy136.61K——
2026-03-10Silver RonaldBuy163.93K——
2026-03-10MCCOURT Thomas ABuy409.84K——
2026-02-24John MinardoSell19.05K$3.6669.73K
2026-02-24Shetzline MichaelBuy17.01K$3.6662.26K
2026-02-24Gaskins Tammi LSell11.24K$3.6641.13K
2026-02-24MCCOURT Thomas ASell103.53K$3.66378.91K
2026-02-24Martini Gregory S.Sell11.46K$3.6641.93K
2026-02-24Silver RonaldSell12.62K$3.6646.19K
2026-02-23John MinardoSell17.44K$3.8166.44K
2026-02-23Shetzline MichaelSell15.57K$3.8159.32K
2026-02-23Gaskins Tammi LSell10.29K$3.8139.19K
2026-02-23MCCOURT Thomas ASell94.76K$3.81361.02K
2026-02-23Martini Gregory S.Sell10.49K$3.8139.96K
2026-02-23Silver RonaldSell11.55K$3.8144.01K
2026-01-05Silver RonaldSell35.42K$4.60162.91K
2025-12-15DENNER ALEXANDER JBuy4.18K——
2025-11-17Gaskins Tammi LSell6.02K$3.3219.97K
2025-09-15DENNER ALEXANDER JBuy11.72K——
2025-08-11Gaskins Tammi LSell1.32K$0.841.11K
2025-08-11John MinardoSell7.75K$0.846.51K
2025-08-11Martini Gregory S.Sell1.26K$0.841.06K
2025-08-11Silver RonaldSell2.85K$0.842.39K
2025-06-13DENNER ALEXANDER JBuy24.19K——
2025-06-10Kessler Marla LBuy45.00K——
2025-06-10Shepard JayBuy45.00K——
2025-06-10Moukheibir CatherineBuy45.00K——
2025-06-10Duane Jon RBuy45.00K——
2025-06-10Currie Mark GBuy45.00K——
2025-06-10McHugh JulieBuy45.00K——
2025-06-10Dreyfus AndrewBuy45.00K——
2025-06-10DENNER ALEXANDER JBuy45.00K——
2025-05-20MCCOURT Thomas ABuy540.00K——
2025-05-16MCCOURT Thomas ASell13.35K$0.587.74K
2025-05-16Gaskins Tammi LSell2.56K$0.581.49K
2025-04-02DENNER ALEXANDER JBuy10.42K——
2025-03-11Gaskins Tammi LOther0——
2025-02-10MCCOURT Thomas ASell139.06K$1.76244.75K
2025-02-10Silver RonaldSell12.05K$1.7621.20K
2025-02-10Shetzline MichaelBuy133.33K——
2025-02-10Shetzline MichaelSell41.27K$1.7672.63K
2025-02-10John MinardoBuy122.22K——
2025-02-10John MinardoSell38.94K$1.7668.53K
2025-02-10Martini Gregory S.Sell12.05K$1.7621.21K
2025-01-27Silver RonaldBuy133.33K——
2025-01-27Martini Gregory S.Buy111.11K——
2025-01-27Martini Gregory S.Other0——
2025-01-27Martini Gregory S.Other0$16.900
2025-01-27Martini Gregory S.Other0$12.950
2025-01-17Shetzline MichaelBuy48.22K——
2025-01-17John MinardoBuy40.19K——
2025-01-17MCCOURT Thomas ABuy147.35K——
2024-12-16DENNER ALEXANDER JBuy4.25K——
2024-11-18Davis AndrewSell5.36K$4.0821.87K
2024-11-18Emany Sravan KumarSell11.00K$4.0844.88K
2024-09-16DENNER ALEXANDER JBuy3.28K——
2024-08-12John MinardoSell9.91K$4.2742.32K
2024-08-12Silver RonaldSell3.11K$4.2713.27K
2024-06-18Shepard JayBuy24.31K——
2024-06-18Dreyfus AndrewBuy24.31K——
2024-06-18Duane Jon RBuy24.31K——
2024-06-18McHugh JulieBuy24.31K——
2024-06-18Moukheibir CatherineBuy24.31K——
2024-06-18Kessler Marla LBuy24.31K——
2024-06-18DENNER ALEXANDER JBuy24.31K——
2024-06-18Currie Mark GBuy24.31K——
2024-06-15DENNER ALEXANDER JBuy2.57K——
2024-06-10McHugh JulieSell22.77K$6.29143.20K
2024-06-07Moukheibir CatherineSell35.57K$6.61235.14K
2024-06-06Moukheibir CatherineSell44.43K$6.36282.55K
2024-05-20MCCOURT Thomas ASell67.62K$6.45436.14K
2024-05-20Davis AndrewSell22.73K$6.45146.58K
2024-05-20Shetzline MichaelSell16.13K$6.45104.03K
2024-05-20John MinardoSell17.40K$6.45112.26K
2024-05-16Emany Sravan KumarSell18.28K$6.64121.38K
2024-03-15DENNER ALEXANDER JBuy1.66K——
2024-03-08John MinardoBuy32.75K——
2024-03-08John MinardoSell32.75K——
2024-03-08Emany Sravan KumarBuy37.12K——
2024-03-08Emany Sravan KumarSell37.12K——

Institutional holders

Latest filed quarter: Q3 2026.

Institutions holding: 148, holders -72 vs prior quarter. Ownership 57.53%.

HolderSharesChangeChange %Value
BLACKROCK, INC.18.48M686.89K+3.86%73.35M
RENAISSANCE TECHNOLOGIES LLC8.04M48.57K+0.61%31.93M
STATE STREET CORP6.72M-2.09M-23.68%26.69M
VANGUARD CAPITAL MANAGEMENT LLC6.63M26.24K+0.40%26.34M
VANGUARD PORTFOLIO MANAGEMENT LLC5.06M-449.55K-8.15%20.10M
ACADIAN ASSET MANAGEMENT LLC5.05M-801.10K-13.69%20.05M
GEODE CAPITAL MANAGEMENT, LLC3.92M-913.66K-18.91%15.56M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP3.38M361.68K+11.99%13.41M
FEDERATED HERMES, INC.3.23M-6.10K-0.19%12.80M
DIMENSIONAL FUND ADVISORS LP2.65M131.69K+5.22%10.54M
MARSHALL WACE, LLP2.57M-1.72M-40.15%10.19M
MACKENZIE FINANCIAL CORP2.32M-44.80K-1.89%9.22M
MORGAN STANLEY1.87M12.90K+0.69%7.44M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.1.75M-61.64K-3.40%6.95M
O'SHAUGHNESSY ASSET MANAGEMENT, LLC1.38M937.70K+213.64%5.19M
FMR LLC1.25M342.64K+37.67%4.97M
FRANKLIN TEMPLETON INC1.27M261.55K+25.97%4.78M
HRT FINANCIAL LP1.09M508.10K+88.01%4.31M
VANGUARD FIDUCIARY TRUST CO1.08M41.52K+3.99%4.29M
QUBE RESEARCH & TECHNOLOGIES LTD865.39K865.39KNew3.44M
RITHOLTZ WEALTH MANAGEMENT831.09K831.09KNew3.30M
RAYMOND JAMES FINANCIAL INC810.39K85.30K+11.76%3.22M
HILLSDALE INVESTMENT MANAGEMENT INC.746.55K-503.87K-40.30%2.96M
VICTORY CAPITAL MANAGEMENT INC678.71K20.26K+3.08%2.69M
FIRST TRUST ADVISORS LP659.73K659.73KNew2.62M

Insights · Forecast · Financials · Learn

Stocklytics home · Screener